Pear Therapeutics, Inc.

EFORMULATION

software for collecting data on a patient's use of and subjective experience with nutritional supplements or medical foods; software for guiding a patient's use of nutritional supplements or medical foods; software for monitoring and improving the efficacy of nutritional supplements or medical foods; software for monitoring and improving the side effects of nutritional supplements or medical foods; software for collecting biometric data from patients;nutritional supplements; medical food supplements;E FORMULATION;

EFORMULATION

The mark consists of the stylized wording EFORMULATION positioned below a stylized capsule design, the right half of which contains a design simulating a QR code.;Software for collecting data on a patient's use of and subjective experience with pharmaceuticals, nutritional supplements, or medical foods; software for guiding a patient's use of pharmaceuticals, nutritional supplements, or medical foods; software for monitoring and improving the efficacy of pharmaceuticals, nutritional supplements, or medical foods; software for monitoring and improving the side effects of pharmaceuticals, nutritional supplements, or medical foods; software for collecting biometric data from patients;pharmaceutical preparations for the prevention and treatment of disorders of the nervous system and metabolic system; pharmaceutical preparations for use in psychiatry and neurology; pharmaceutical preparations for the prevention and treatment of pain, chronic pain, acute pain, depression, anxiety disorders, post-traumatic stress disorder, traumatic brain injury, attention deficit disorder, hyperactivity disorder, schizophrenia, epilepsy, migraine, bipolar disorders, sleep disorders, circadian disorders, addiction, obsessive compulsive disorder, autism spectrum disorders, cognitive decline, diabetes, and obesity; nutritional supplements; medical food supplements;E FORMULATION;Color is not claimed as a feature of the mark.;DESIGN OF THE QUICK RESPONSE CODE;